Related Experiment Video
Updated: Jun 10, 2026
12:02
Using Tg(Vtg1:mcherry) Zebrafish Embryos to Test the Estrogenic Effects of Endocrine Disrupting Compounds
Published on: August 8, 2020
genotoxic effects induced by beta-oestradiol in vitro.
1Department of Toxicology, University of Würzburg, Versbacher Str. 9, 97078, Würzburg, Germany.
Summary
The hormone beta-estradiol causes DNA damage in mammalian cells. This study shows it disrupts cell division, leading to micronuclei formation and impaired chromosome separation.
Area of Science:
- Toxicology
- Cell Biology
- Genetics
Background:
- Beta-estradiol is an endogenous hormone with carcinogenic properties.
- Genotoxic effects of beta-estradiol have been observed in mammalian test systems.
Purpose of the Study:
- To investigate the mechanism of micronucleus induction by beta-estradiol in V79 cells.
- To understand the role of mitotic disturbances in beta-estradiol genotoxicity.
Main Methods:
- Micronucleus induction assays in V79 cells.
- Analysis of metaphase chromosome arrangements.
- Live-cell imaging to observe chromosome behavior during mitosis.
Main Results:
- Early induction of kinetochore-positive micronuclei suggests mitotic disruption.
- Displaced chromosomes were observed in metaphase, but mostly reintegrated in live cells.
- Impaired chromatid separation and chromatin fragment formation occurred in some cells.
Conclusions:
- Beta-estradiol induces genotoxicity through mechanisms involving mitotic disturbances.
- While chromosome loss may contribute, impaired chromatid separation is a significant factor.
- Further research is needed to fully elucidate the genotoxic pathways of beta-estradiol.
More Related Videos
Related Concept Videos
01:16In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...